(Sharecast News) - Analysts at Berenberg raised their price target for Hikma Pharmaceuticals from 1,800p to 2,100p on Tuesday, saying the business was "moving in the right direction" following a stronger‑than‑expected first half.
Berenberg said Hikma's share price has largely recovered since February's FY25 results, when the group withdrew its medium‑term...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE